Comparative outcomes of middle meningeal artery embolization for chronic subdural hematoma: A comprehensive systematic review,meta-analysis,meta-regression and network meta-analysis
Restricted accessReview articleFirst published online 2025
Comparative outcomes of middle meningeal artery embolization for chronic subdural hematoma: A comprehensive systematic review,meta-analysis,meta-regression and network meta-analysis
Middle meningeal artery embolization (MMAE) has emerged as a promising minimally invasive approach for chronic subdural hematoma (cSDH). We aimed to compare the effectiveness of middle meningeal artery embolization (MMAE) as a standalone therapy, MMAE combined with surgery, and surgery alone, while also compare embolic agents (Onyx, NBCA, particles), and access approaches (femoral vs. radial).
Methods
We systematically searched PubMed, Scopus, and Web of Science through January 2025 for comparative studies focusing on MMAE and surgery in cSDH. Primary outcomes were recurrence and rescue surgery.
Results
A total of 44 studies (39 observational and 5 randomized controlled trials) met inclusion criteria. MMAE alone (OR: 0.39; CI: 0.25 to 0.64) and adjunctive MMAE (OR: 0.40; CI: 0.29 to 0.55) had lower recurrence rates compared to surgery alone. However, there were no significant differences in complication rates or functional outcome (mRS 0–2) at the last follow-up. Onyx was associated with the lowest surgical rescue needs and radial access trended toward fewer access site complications compared to femoral access.
Conclusion
MMAE, whether used alone or as an adjunct, is associated with significantly lower recurrence and fewer complications than surgery alone. Choice of embolic agent and radial access may also confer additional benefits. These findings emphasize the need for a comprehensive and tailored approach when utilizing MMAE to treat cSDH. Further studies are needed.
JiangRZhaoSWangR, et al.Safety and efficacy of atorvastatin for chronic subdural hematoma in Chinese patients: a randomized ClinicalTrial. JAMA Neurol2018; 75: 1338–1346.
2.
RauhalaMHelénPHuhtalaH, et al.Chronic subdural hematoma-incidence, complications, and financial impact. Acta Neurochir (Wien)2020; 162: 2033–2043.
3.
MusmarBSpellicySSalimH, et al.Comparative outcomes of middle meningeal artery embolization with statins versus embolization alone in the treatment of chronic subdural hematoma: a systematic review and meta-analysis. Neurosurg Rev2023; 46: 262.
4.
MoshayediPLiebeskindDS. Middle meningeal artery embolization in chronic subdural hematoma: implications of pathophysiology in trial design. Front Neurol2020; 11: 23.
5.
FeghaliJYangWHuangJ. Updates in chronic subdural hematoma: epidemiology, etiology, pathogenesis, treatment, and outcome. World Neurosurg2020; 141: 339–345.
6.
CofanoFPesceAVercelliG, et al.Risk of recurrence of chronic subdural hematomas after surgery: a multicenter observational cohort study. Front Neurol2020; 11: 560269.
7.
MiahIPHollDCBlaauwJ, et al.Dexamethasone versus surgery for chronic subdural hematoma. N Engl J Med2023; 388: 2230–2240.
8.
HutchinsonPJEdlmannEBultersD, et al.Trial of dexamethasone for chronic subdural hematoma. N Engl J Med2020; 383: 2616–2627.
9.
DucruetAFGrobelnyBTZachariaBE, et al.The surgical management of chronic subdural hematoma. Neurosurg Rev2012; 35: 155–169. discussion 169.
10.
RajahGBWaqasMDossaniRH, et al.Transradial middle meningeal artery embolization for chronic subdural hematoma using Onyx: case series. J Neurointerventional Surg2020; 12: 1214–1218.
11.
WaqasMVakhariKWeimerPV, et al.Safety and effectiveness of embolization for chronic subdural hematoma. Systematic Review and Case Series. World Neurosurg2019; 126: 228–236.
12.
KanPMaragkosGASrivatsanA, et al.Middle meningeal artery embolization for chronic subdural hematoma: a multi-center experience of 154 consecutive embolizations. Neurosurgery2021; 88: 268–277.
13.
QiaoYAlkarawiSProvasekVE, et al.Chronic subdural hematoma: what precisely are we treating?Interv NeuroradiolPublished online July 21, 2024: 15910199241263633. doi:10.1177/15910199241263633
14.
DésirLLD’AmicoRLinkT, et al.Middle meningeal artery embolization and the treatment of a chronic subdural hematoma. Cureus2021; 13: e18868.
15.
ShakirMIrshadHAAlidinaZ, et al.Middle meningeal artery embolization (MMAE) alone versus combined with conventional surgery in the management of chronic subdural hematoma (cSDH): a systematic review and meta-analysis. Clin Neurol Neurosurg246: 108580. doi:https://doi.org/10.1016/j.clineuro.2024.108580. Epub 2024 Oct 3. PMID: 39395281.
16.
SrivatsanAMohantyANascimentoFA, et al.Middle meningeal artery embolization for chronic subdural hematoma: meta-analysis and systematic review. World Neurosurg2019; 122: 613–619.
17.
ShankarJAlcockSMilotG. Embolization of middle meningeal artery for chronic subdural hematoma: Do we have sufficient evidence?Interv Neuroradiol2025; 31: 5–7.
18.
PageMJMcKenzieJEBossuytPM, et al.The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Br Med J2021; 372: n71.
19.
OuzzaniMHammadyHFedorowiczZ, et al.Rayyan-a web and mobile app for systematic reviews. Syst Rev2016; 5: 210.
KimE. Embolization therapy for refractory hemorrhage in patients with chronic subdural hematomas. World Neurosurg2017; 101: 520–527.
23.
BanSPHwangGByounHS, et al.Middle meningeal artery embolization for chronic subdural hematoma. Radiology2018; 286: 992–999.
24.
ShotarEMeyblumLPrematK, et al.Middle meningeal artery embolization reduces the post-operative recurrence rate of at-risk chronic subdural hematoma. J Neurointerventional Surg2020; 12: 1209–1213.
25.
NgSDerrazIBoettoJ, et al.Middle meningeal artery embolization as an adjuvant treatment to surgery for symptomatic chronic subdural hematoma: a pilot study assessing hematoma volume resorption. J Neurointerventional Surg2020; 12: 695–699.
26.
ChenHSalemMMColasurdoM, et al.Standalone middle meningeal artery embolization versus middle meningeal artery embolization with concurrent surgical evacuation for chronic subdural hematomas: a multicenter propensity score matched analysis of clinical and radiographic outcomes. J Neurointerventional Surg2024; 16: 1313–1319.
27.
SalihMShutranMYoungM, et al.Reduced recurrence of chronic subdural hematomas treated with open surgery followed by middle meningeal artery embolization compared to open surgery alone: a propensity score-matched analysis. J Neurosurg2023; 139: 124–130.
28.
OnyinzoCBerlisAAbelM, et al.Efficacy and mid-term outcome of middle meningeal artery embolization with or without burr hole evacuation for chronic subdural hematoma compared with burr hole evacuation alone. J Neurointerventional Surg2022; 14: 297–300.
29.
HousleySBMonteiroAKhawarWI, et al.Volumetric resolution of chronic subdural hematomas treated with surgical evacuation versus middle meningeal artery embolization during immediate, early, and late follow up: propensity-score matched cohorts. J Neurointerventional Surg2023; 15: 943–947.
30.
Enriquez-MarulandaAGomez-PazSSalemMM, et al.Middle meningeal artery embolization versus conventional treatment of chronic subdural hematomas. Neurosurgery2021; 89: 486–495.
31.
CarpenterARockMDowlatiE, et al.Middle meningeal artery embolization with subdural evacuating port system for primary management of chronic subdural hematomas. Neurosurg Rev2022; 45: 439–449.
32.
LamASelvarajahDHtikeSS, et al.The efficacy of postoperative middle meningeal artery embolization on chronic subdural hematoma - A multicentered randomized controlled trial. Surg Neurol Int2023; 14: 68.
33.
SioutasGSMouchtourisNSaieghFA, et al.Middle meningeal artery embolization for subdural hematoma: an institutional cohort and propensity score-matched comparison with conventional management. Clin Neurol Neurosurg2023; 233: 107895.
34.
SilaDCasnatiFLVojtkováM, et al.Middle meningeal artery embolization versus surgery in patients with chronic subdural hematoma-No more fence sitting?Neurol Int2023; 15: 1480–1488.
35.
SalihMKhorasanizadehMMcMillanN, et al.Cost comparison for open surgery versus middle meningeal artery embolization in patients with chronic subdural hematomas: a propensity score-matched analysis. World Neurosurg2023; 172: e94–e99.
36.
CatapanoJSKoesterSWSrinivasanVM, et al.Total 1-year hospital cost of middle meningeal artery embolization compared to surgery for chronic subdural hematomas: a propensity-adjusted analysis. J Neurointerventional Surg2022; 14: 804–806.
37.
NiaAMSrinivasanVMSiddiqF, et al.Trends and outcomes of primary, rescue, and adjunct middle meningeal artery embolization for chronic subdural hematomas. World Neurosurg2022; 164: e568–e573.
38.
McCannCPBrandelMGWaliAR, et al.Safety of middle meningeal artery embolization for treatment of subdural hematoma: a nationwide propensity score matched analysis. J Cerebrovasc Endovasc Neurosurg2023; 25: 380–389.
39.
LiebertAVoit-HöhneHRitterL, et al.Embolization of the middle meningeal artery vs. Second surgery-treatment response and volume course of recurrent chronic subdural hematomas. Acta Neurochir (Wien)2023; 165: 1967–1974.
40.
KhorasanizadehMMaroufiSFMukherjeeR, et al.Middle meningeal artery embolization in adjunction to surgical evacuation for treatment of subdural hematomas: a nationwide comparison of outcomes with isolated surgical evacuation. Neurosurgery2023; 93: 1082–1089.
41.
DicpinigaitisAJAl-MuftiFCooperJB, et al.Nationwide trends in middle meningeal artery embolization for treatment of chronic subdural hematoma: a population-based analysis of utilization and short-term outcomes. J Clin Neurosci Off J Neurosurg Soc Australas2021; 94: 70–75.
42.
CatapanoJSDucruetAFNguyenCL, et al.A propensity-adjusted comparison of middle meningeal artery embolization versus conventional therapy for chronic subdural hematomas. J Neurosurg2021; 135: 1208–1213.
43.
CatapanoJSScherschinskiLRumallaK, et al.Emergency department visits for chronic subdural hematomas within 30 days after surgical evacuation with and without middle meningeal artery embolization. AJNR Am J Neuroradiol2022; 43: 1148–1151.
44.
DebsLHValeFLWalkerS, et al.Middle meningeal artery embolization following surgical evacuation of symptomatic chronic subdural hematoma improves outcomes, interim results of a prospective randomized trial. J Clin Neurosci Off J Neurosurg Soc Australas2024; 128: 110783.
45.
FujiokaMIshiiYChibaK, et al.Validity of the cost-effectiveness of middle meningeal artery embolization following hematoma evacuation for initial chronic subdural hematoma. World Neurosurg2024; 190: e175–e180.
46.
WangYWangWHuangQ, et al.Middle Meningeal Artery Embolization Reduces the Recurrence Rate of Chronic Subdural Hematoma: A Propensity Score Matching Analysis. J Craniofac Surg. Published online September 17, 2024. doi:10.1097/SCS.0000000000010650
47.
DuangprasertGSukhorSNoiphithakR, et al.Comparison of adjunctive middle meningeal artery embolization using embosphere particles versus surgical drainage alone for the treatment of chronic subdural hematoma: a prospective study. J Clin Neurosci Off J Neurosurg Soc Australas2024; 128: 110808.
48.
SioutasGSShekhtmanODagliMM, et al.Middle meningeal artery patency after surgical evacuation for chronic subdural hematoma. Neurosurg Rev2024; 47: 45.
49.
Martinez-GutierrezJCDawesBHZeineddineHA, et al.Middle meningeal artery embolization reduces recurrence following surgery for septated chronic subdural hematomas. Clin Neurol Neurosurg2024; 240: 108252.
50.
PerngPSChuangMTWongCE, et al.Simple coiling of middle meningeal artery embolization for chronic subdural hematoma: an inverse probability of treatment weighting matched cohort study. Interv Neuroradiol J Peritherapeutic Neuroradiol Surg Proced Relat NeurosciPublished online February 28, 2024: 15910199241234407. doi:10.1177/15910199241234407
51.
ChengWYangQYuanX, et al.Comparison of clinical efficacy of MMA embolization combined with subdural perforation drainage and subdural perforation drainage in the treatment of CSDH. Neurocir Engl EdPublished online November 17, 2024: S2529-8496(24)00067-4. doi:10.1016/j.neucie.2024.11.001
52.
LiuJNiWZuoQ, et al.Middle meningeal artery embolization for nonacute subdural hematoma. N Engl J Med2024; 391: 1901–1912.
53.
DaviesJMKnopmanJMokinM, et al.Adjunctive middle meningeal artery embolization for subdural hematoma. N Engl J Med2024; 391: 1890–1900.
54.
MatsumotoHHanayamaHOkadaT, et al.Which surgical procedure is effective for refractory chronic subdural hematoma? Analysis of our surgical procedures and literature review. J Clin Neurosci Off J Neurosurg Soc Australas2018; 49: 40–47.
55.
ZhangZLimJXWenD, et al.Adjunct middle meningeal artery embolization versus surgery for chronic subdural hematoma: a systematic review and meta-analysis. Neurosurg Rev2024; 47: 876.
56.
SalemMMHelalAGajjarAA, et al.Embolic materials’ comparison in meningeal artery embolization for chronic subdural hematomas: Multicenter propensity score-matched analysis of 1070 cases. Neurosurgery. Published online October 17, 2024. doi:10.1227/neu.0000000000003218
57.
MaLHozSSDoheimMF, et al.Impact of embolisate penetration, type, and technique on results after standalone middle meningeal artery embolization for chronic subdural hematoma. Neurosurgery2024; 95: 1395–1406.
58.
EllensNRSchartzDKohliG, et al.Safety and efficacy comparison of embolic agents for middle meningeal artery embolization for chronic subdural hematoma. J Cerebrovasc Endovasc Neurosurg2024; 26: 11–22.
59.
CatapanoJSDucruetAFNguyenCL, et al.Middle meningeal artery embolization for chronic subdural hematoma: an institutional technical analysis. J Neurointerventional Surg2021; 13: 657–660.
60.
KrothapalliNPatelSFayadM, et al.Outcomes of particle versus liquid embolic materials used in middle meningeal artery embolization for the treatment of chronic subdural hematoma. World Neurosurg2023; 173: e27–e36.
61.
ShehabeldinMAmllayAJabreR, et al.Onyx versus particles for middle meningeal artery embolization in chronic subdural hematoma. Neurosurgery2023; 92: 979–985.
62.
ScovilleJPJoyceEA TonettiD, et al.Radiographic and clinical outcomes with particle or liquid embolic agents for middle meningeal artery embolization of nonacute subdural hematomas. Interv Neuroradiol J Peritherapeutic Neuroradiol Surg Proced Relat Neurosci2023; 29: 683–690.
63.
HungARanKDasO, et al.Transradial approach for middle meningeal artery embolization is a safe alternative to transfemoral approach in patients with chronic subdural hematoma: a single-center retrospective comparative study. Clin Neurol Neurosurg2024; 246: 108525.
64.
SalemMMSioutasGSGajjarA, et al.Femoral versus radial access for middle meningeal artery embolization for chronic subdural hematomas: multicenter propensity score matched study. J Neurointerventional SurgPublished online July 11, 2024: jnis-2024-021880. doi:10.1136/jnis-2024-021880
65.
ShankarJ. Embolization of middle meningeal artery (EMMA) for non-acute subdural hematoma: insight from recent randomized trials and meta-analysis. Interv NeuroradiolPublished online February 3, 2025: 15910199251318408. doi:10.1177/15910199251318408
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
